Business

Biotech Implosion: AtheroGenics (AGIX)

AtheroGenics Inc. (AGIX-NASDAQ) is the latest biotech implosion this morning.  It went from bad to worse as its late-stage clinical study for heart disease treatment failed to meet endpoints, although ...
Read Full Story »

Cramer’s Biotech Zombie Looking Up

On Friday's MAD MONEY on CNBC, Jim Cramer discussed Nastech Pharma (NSTK).  This is one of the biotech zombies that has fallen from grace, but Cramer thinks they have some ...
Read Full Story »

Media Digest 3/29/2006 Reuters, NYTimes, SWJ, FT, Barron’s

According to Reuters, several British newspapers have confimed that Barclays (BCS) is in merger talks with ABN Amro.Reuters writes that the head of United Airlines says he would support "open ...
Read Full Story »

The Monday Edition- Going Gold

By Yaser Anwar, CSC of Equity Investment IdeasThis week I'd like to cover topics surrounding gold. From a) Market Sentiment to b) Demand and c) Supply to d) Implications of ...
Read Full Story »

High Cost of New Cancer Drugs Force Government Intervention

From BioHealth Investorby H.S. AyoubBioHealth Investor.comMorgan Stanley analyst Steven Harr has been warning Genentech and other drug firms that the record prices asked for new cancer drug treatments could create ...
Read Full Story »

Could GM Get Chrysler Cheap

DaimlerChrysler's (DCX) unions are objecting to the company selling its US arm, Chrysler, to private equity interests. Labor representatives hold half the seats on the DCX board, and it appears ...
Read Full Story »

Barron’s Digest March 19, 2007 Issue

Barron's writes that efforts by Clear Channel (CCU) to complete its IPO may not be successful as some of its institutional holders dig in for a better price.Textron's (TXT) stock ...
Read Full Story »

The Consolidated Week of Cramer

Cramer had many picks this week, here is an abbreviated list:On Friday evening he started out telling investors that they need to own Caterpillar (CAT) and he even went in ...
Read Full Story »

Cramer’s Playbook for Next Week

On CNBC's MAD MONEY Cramer has a gameplan for next week.  Cramer noted that the success of the movie "300" is not big enough to help the Time Warner (TWX) ...
Read Full Story »

Cramer Talks Nastech

On tonight's MAD MONEY on CNBC, Jim Cramer discussed Regenron (REGN) as one where he had interviewed the CEo of the company back when he started doing MAD MONEY.  This ...
Read Full Story »

Cramer on a Cat’s Meow

On tonight's MAD MONEY on CNBC, Jim Cramer said that Carerpillar (CAT) is being kept down too low.  Cramer think sthe Chinese are back into buying commodities and the companu ...
Read Full Story »

The Week of Cramer (MAR 16, 2007)

Very soon we'll have another evening of Cramer's MAD MONEY.  Tonight we should get another one of his speculative plays in medical or elsewhere, assuming that the weak market did ...
Read Full Story »

Cramer Talks the Drop & Commodities

On today's STOP TRADING segment on CNBC, Jim Cramer addressed the drop today potentially being a rough day because of options expiration and with so many people having left the ...
Read Full Story »

LEND: Accredited Lives to Fight Another Battle

By William Trent, CFA of Stock Market BeatSubprime lender Accredited in deal to sell loans - Yahoo! NewsU.S. subprime mortgage lender Accredited Home Lenders Holding Co. (LEND) said it reached ...
Read Full Story »
Redstone

Viacom’s Redstone Just Hedging Google/YouTube Bets?

From Internet OursiderOne massive old media conglomerate, Viacom, is so outraged about Google's "willful copyright infringement" that it is suing Google for $1 billion.  Another massive old media conglomerate, CBS, ...
Read Full Story »